Deep Origin
Deep Origin is a biotechnology company that specializes in providing a platform designed to enhance life sciences research and development. The company develops accelerator technology software aimed at assisting biotechnology firms in speeding up early-stage drug research and development. Its platform features advanced yet user-friendly tools tailored for biomedical scientists and engineers, empowering them to advance scientific discoveries in the field. By facilitating innovation, Deep Origin supports the ongoing evolution of biomedicine and the exploration of new therapeutic solutions.
1 past transactions
Biosim AI
Acquisition in 2024
Biosim AI is a medical technology company focused on enhancing and expediting the drug discovery process using advanced artificial intelligence. By leveraging quantum accuracy, the company develops innovative methods to significantly reduce the timeline associated with identifying and developing new pharmaceuticals. Biosim AI aims to address the challenges of discovering treatments for diseases that have traditionally been considered undruggable, ultimately benefiting both patients and the broader medical community.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.